Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies
- PMID: 1388703
- DOI: 10.1007/BF02260081
Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies
Abstract
Acetylcholinesterase (AChE), an enzyme responsible for the break-down of acetylcholine, is found both in cholinergic and non-cholinergic neurons in the central nervous system. In addition to its role in the catabolism of acetylcholine, AChE have other functions in brain, e.g. in the processing of peptides and proteins, and in the modulation of dopaminergic neurons in the brain stem. Several clinical and experimental studies have investigated AChE in brain and cerebrospinal fluid (CSF) in aging and dementia. The results suggest that brain AChE and its molecular forms show interesting changes in dementia and aging. However, CSF-AChE activity is not a very reliable or sensitive marker of the integrity and function of cholinergic neurons in the basal forebrain complex. Additional work is needed to clarify the role of AChE abnormality in the formation of pathology changes in patients with Alzheimer's disease.
Similar articles
-
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.J Neurol Neurosurg Psychiatry. 1987 May;50(5):538-43. doi: 10.1136/jnnp.50.5.538. J Neurol Neurosurg Psychiatry. 1987. PMID: 2953866 Free PMC article.
-
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.Brain. 1987 Oct;110 ( Pt 5):1309-22. doi: 10.1093/brain/110.5.1309. Brain. 1987. PMID: 3676702
-
Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.Ann Neurol. 1988 Feb;23(2):161-7. doi: 10.1002/ana.410230209. Ann Neurol. 1988. PMID: 3377438
-
Cholinesterases: new roles in brain function and in Alzheimer's disease.Neurochem Res. 2003 Apr;28(3-4):515-22. doi: 10.1023/a:1022869222652. Neurochem Res. 2003. PMID: 12675140 Review.
-
Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies.Curr Alzheimer Res. 2010 Feb;7(1):67-73. doi: 10.2174/156720510790274455. Curr Alzheimer Res. 2010. PMID: 20205672 Review.
Cited by
-
The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats.J Neural Transm (Vienna). 1996;103(5):619-26. doi: 10.1007/BF01273158. J Neural Transm (Vienna). 1996. PMID: 8811506
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical